Drug delivery system with control valve

By designing valve components in the drug delivery system to control fluid communication and distribution, the problem of excessive delivery of medical fluids in traditional systems is solved, and the drug is efficient and non-overloaded, which is suitable for the needs of patients with fluid restriction.

CN114126685BActive Publication Date: 2024-11-12CAREFUSION 303 INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080047119.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-05-03
Filing Date
2020-05-01
Publication Date
2024-11-12
Estimated Expiration
2040-05-01

AI Technical Summary

Technical Problem

Traditional drug delivery systems may deliver excessive medical fluids, such as saline, to patients, resulting in delays in delivery that are not suitable for patients with fluid restriction, such as premature infants.

Method used

A valve is designed to allow fluid communication in the perfusion and distribution position through the valve element and control fluid flow at the catheter position to ensure that the drug is separated from the saline, avoiding saline entering the patient, and achieving efficient and excessive delivery of the drug.

Benefits of technology

Effectively reduces excessive fluid delivered to patients, ensuring that the drug passes through the catheter with less delay and less saline, suitable for the needs of patients with fluid restriction.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114126685B_ABST
    Figure CN114126685B_ABST
Patent Text Reader

Abstract

A valve and a drug delivery system including the valve are described herein. The valve includes a valve body and a valve element. The valve body defines a first flow path, a second flow path, and a catheter flow path. The valve element is disposed within the valve body, wherein the valve element is configured to allow fluid communication between the first flow path and the second flow path in a priming position, and is configured to allow fluid communication between the first flow path and the catheter flow path in a dispensing position.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates generally to drug delivery systems and, more particularly, to valves. Background Art

[0002] Medical treatments often involve infusing a patient with a medical fluid (e.g., saline solution or liquid medication) using an intravenous (IV) catheter that is connected to a fluid source, such as a syringe, by an arrangement of flexible tubing and fittings, commonly referred to as an "IV set." Certain configurations of IV sets may have extended lengths of tubing, e.g., more than 6 feet. Additionally, the tubing may be primed with saline prior to infusing the liquid medication.

[0003] In some applications, during use of an IV catheter, saline from a priming procedure may be delivered to the patient prior to delivering liquid medication to the patient. Summary of the invention

[0004] The disclosed subject matter relates to valves. In certain embodiments, a valve is disclosed that includes: a valve body that defines a first flow path, a second flow path, and a conduit flow path; and a valve element disposed within the valve body, wherein the valve element is configured to allow fluid communication between the first flow path and the second flow path in a priming position, and is configured to allow fluid communication between the first flow path and the conduit flow path in a dispensing position.

[0005] In certain embodiments, a drug delivery system including a syringe and a valve is disclosed. The syringe includes: a syringe body defining a syringe cavity; a first plunger disposed in the syringe cavity and defining a first chamber in the syringe cavity; a second plunger disposed in the syringe cavity, the second plunger defining a second chamber in the syringe cavity. The valve includes: a valve body defining a first valve flow path in fluid communication with the first chamber, a second valve flow path in fluid communication with the second chamber, and a conduit flow path in fluid communication with a conduit; and a valve element disposed in the valve body, wherein the valve element is configured to allow fluid communication between the first chamber and the second chamber in a priming position, and is configured to allow fluid communication between the first chamber and the conduit flow path in a dispensing position.

[0006] In certain embodiments, a method of delivering a drug is disclosed, the method comprising introducing saline into a drug flow path; and directing saline from the drug flow path to a return flow path via a valve element; and introducing a drug into the drug flow path; actuating the valve element to allow fluid communication between the drug flow path and a catheter; and directing the drug from the drug flow path into the catheter.

[0007] It should be understood that, in light of this disclosure, various configurations of the subject technology will become apparent to those skilled in the art, wherein the various configurations of the subject technology are shown and described by way of illustration. As will be appreciated, the subject technology can have other and different configurations, and its several details can be modified in various other aspects, all without departing from the scope of the subject technology. Therefore, the summary of the invention, the description of the drawings, and the specific embodiments are considered to be illustrative in nature, rather than restrictive. BRIEF DESCRIPTION OF THE DRAWINGS

[0008] The accompanying drawings, which are included to provide a further understanding and are incorporated in and constitute a part of this specification, illustrate the disclosed embodiments and, together with the description, serve to explain the principles of the disclosed embodiments. In the drawings:

[0009] Figure 1 is a perspective view of a drug delivery system according to various aspects of the present disclosure.

[0010] Figure 2 According to various aspects of the present disclosure Figure 1 A perspective view of the drug delivery system with the priming trigger removed.

[0011] Figure 3 According to various aspects of the present disclosure Figure 1 A perspective view of a drug delivery system with a syringe being actuated.

[0012] Figure 4 According to various aspects of the present disclosure Figure 1 A perspective view of a drug delivery system with a syringe being actuated.

[0013] Figure 5 is a front view of a syringe according to various aspects of the present disclosure, wherein the syringe body is hidden.

[0014] Figure 6 According to various aspects of the present disclosure Figure 5 Front view of the syringe with the syringe body hidden and the priming trigger removed.

[0015] Figure 7 According to various aspects of the present disclosure Figure 5 A front view of a syringe with the syringe body hidden and the priming mechanism actuated.

[0016] Figure 8 According to various aspects of the present disclosure Figure 5 A front view of a syringe with the syringe body hidden and the syringe actuated. DETAILED DESCRIPTION

[0017] The disclosed valve incorporates a valve element to direct the flow for priming and dispensing a medical fluid. In the priming configuration, the fluid can flow from a first flow path to a second flow path, and in the dispensing position, the fluid can flow from the first flow path to a catheter flow path. By controlling the flow of fluid through the valve, medication can be administered without dispensing excess medical fluid.

[0018] The detailed description set forth below is intended to be a description of the various configurations of the subject technology, and is not intended to represent the unique configuration that can practice the subject technology. The detailed description includes specific details, and the purpose is to provide a thorough understanding of the subject technology. However, it is obvious to those skilled in the art that the subject technology can be practiced without these specific details. In some cases, well-known structures and components are shown in the form of block diagrams to avoid blurring the concept of the subject technology. For ease of understanding, identical components are marked with identical element numbers. Reference numerals may have additional letter suffixes to represent different instances of common elements, and common elements are generally referred to by the same numerals without suffix letters.

[0019] Although the following description is directed to the administration of medical fluids using the disclosed valves, it should be understood that the description is merely an example of use and does not limit the scope of the claims. The various aspects of the disclosed valves may be used in any application where it is desired to control the flow of medical fluids.

[0020] The disclosed valve overcomes several challenges found with certain conventional drug delivery systems. One challenge with certain conventional delivery systems is that the system may deliver an excess of medical fluid, such as saline, to a patient. Because the excess medical fluid may delay the delivery of the medical fluid and may not be tolerated by fluid-restricted patients (e.g., premature infants), it is undesirable to use conventional drug delivery systems.

[0021] Therefore, in accordance with the present disclosure, it would be advantageous to provide a valve as described herein that eliminates or significantly reduces the delivery of excess medical fluid to a patient. The disclosed valve provides a valve element that allows for the dispensing of medical fluids while minimizing the delivery of excess fluid to a patient.

[0022] Examples of valves that prevent excessive delivery of medical fluids are now described.

[0023] Figure 1 is a perspective view of a drug delivery system 100 according to various aspects of the present disclosure. In the illustrated example, the drug delivery system 100 delivers a drug from a syringe 130 to a patient via a catheter 112 without delivering excess fluid, such as saline, for priming the drug delivery system 100 .

[0024] In some embodiments, the drug flow path within the dual lumen tubing 120 may be irrigated with saline to remove any air or trapped gas within the drug flow path of the dual lumen tubing 120. Saline may be pushed from the proximal end 132 of the syringe 130, through the drug flow path of the dual lumen tubing 120 and to the valve 110.

[0025] Saline from the drug flow path of the dual lumen tubing 120 can be received by the drug flow path 111 of the valve 110. In the priming configuration, the valve element 113 can prevent saline from the drug flow path 111 from entering the patient conduit 112, and can instead direct the saline toward the return flow path 109 of the valve 110 to allow the priming saline to return to the syringe 130 via the return flow path of the dual lumen tubing 120.

[0026] Figure 2 According to various aspects of the present disclosure Figure 1 1 is a perspective view of a drug delivery system 100 with the priming trigger 180 removed. In the illustrated example, the syringe 130 advances the drug within the drug flow path of the dual lumen tubing 120 to prime the drug flow path of the dual lumen tubing 120. Advantageously, by priming the drug flow path with the drug, the drug can be delivered to the patient via the catheter 112 proximate to the patient with less delay without delivering saline for priming the drug flow path of the dual lumen tubing 120.

[0027] To introduce the drug into the drug flow path of the dual-lumen tubing 120, the drug plunger within the syringe 130 can be advanced or otherwise displaced to introduce a volume of the drug into the drug flow path of the dual-lumen tubing 120. Alternatively, the drug plunger of the syringe 130 can be configured to be advanced or displaced a desired amount to dispense a volume of the drug into the drug flow path of the dual-lumen tubing 120, the volume being equal to the volume of the drug flow path of the dual-lumen tubing 120. In other words, the drug plunger of the syringe 130 can be advanced to fill the volume of the drug flow path of the dual-lumen tubing 120 up to the valve element 113, thereby priming the drug for administration via the catheter 112.

[0028] In some embodiments, the infusion of the drug into the drug flow path of the dual-lumen tubing 120 can be automated or otherwise simplified. For example, the drug plunger can be biased to advance, thereby introducing the drug into the drug flow path of the dual-lumen tubing 120. The biasing member of the infusion mechanism within the syringe 130 can be released by removing the infusion trigger 180. By removing the infusion trigger 180, the biasing member can advance the drug plunger to infuse the drug within the drug delivery system 100. Optionally, the infusion stroke of the drug plunger can be stopped or limited by the infusion stop 182. By limiting the stroke of the drug plunger during infusion, a desired volume of drug (e.g., a volume of drug sufficient to fill the drug flow path of the dual-lumen tubing 120) can be introduced into the drug flow path of the dual-lumen tubing 120.

[0029] As shown, as the drug is introduced into the drug flow path of the double lumen tubing 120, the saline previously infused through the double lumen tubing 120 is displaced. The displaced saline is guided by the valve element 113 through the return flow path 109 of the valve 110 and into the return flow path of the double lumen tubing 120.

[0030] The medical fluid from the return flow path of the dual lumen tubing 120 can be returned to the syringe 130. The returning medical fluid (eg, saline) can be introduced into the return chamber or saline chamber of the syringe 130.

[0031] Figure 3 According to various aspects of the present disclosure Figure 1 100, wherein the syringe 130 is actuated. In the illustrated example, the syringe 130 is actuated to dispense the drug to the patient through the catheter 112.

[0032] As shown, the distal end 134 of the syringe 130 can be advanced toward the proximal end 132 of the syringe 130 to actuate the drug plunger within the syringe 130. The drug plunger can be advanced by actuating the syringe 130 to deliver the drug from the syringe 130 into the drug flow path of the dual-lumen tubing 120. In some embodiments, the syringe 130 can be actuated by a syringe pump to control the flow of the drug to the patient.

[0033] During operation, valve 110 is actuated to allow drug to flow from drug flow path 111 of valve 110 to the patient via conduit 112. In some embodiments, valve element 113 is actuated to allow fluid communication between drug flow path 111 and conduit 112, thereby allowing drug to flow to the patient. Alternatively, valve 110 can be located near the patient to minimize the length of conduit 112, reduce the amount of saline administered to the patient, and reduce the delivery time of the drug.

[0034] In some embodiments, the position of valve element 113 can be actuated between directing flow between drug flow path 111 and return flow path 109 (prime position) and directing flow between drug flow path 111 and conduit 112 (dispense position) by physically manipulating valve 110. For example, valve 110 can be actuated or manipulated by twisting, pushing, shifting, or otherwise actuating valve 110, thereby actuating valve element 113. In some embodiments, valve element 113 can be actuated by a pressure signal or pulse received by valve element 113 from within drug flow path 111 and / or return flow path 109. For example, valve element 113 can be actuated from the prime position to the dispense position by receiving a pressure pulse in drug flow path 111 and / or return flow path 109.

[0035] In some embodiments, valve 110 may be an anti-siphon valve. Alternatively, valve 110 may have a high "cracking pressure" whereby valve element 113 may move from the priming position to the dispensing position if sufficient pressure is applied to valve element 113. For example, valve element 113 may be actuated from the priming position to the dispensing position by receiving an equalized pressure in drug flow path 111 and return flow path 109. Syringe 130 may provide a suitable pressure signal.

[0036] Figure 4 According to various aspects of the present disclosure Figure 1 1 is a perspective view of a drug delivery system 100 in which a syringe 130 is actuated. In the illustrated example, the syringe 130 advances saline through the drug flow path of the dual-lumen tubing 120 to advance the remaining drug to the patient via the catheter 112.

[0037] As shown, after the drug is expelled from the syringe 130, the drug may remain in the volume of the drug flow path of the dual lumen tubing 120. To ensure that the drug is completely delivered to the patient, after the drug in the syringe 130 is expelled, a saline "push" can be applied using the syringe 130 to continue to advance the drug through the drug flow path of the dual lumen tubing 120. Alternatively, saline can be applied through the drug flow path until the drug is completely administered to the patient.

[0038] Figure 5 2 is a front view of a syringe 230 according to various aspects of the present disclosure, wherein the syringe body is hidden. In the drawings, similar features may be represented by similar reference numerals. In the depicted example, the syringe 230 can be used to dispense medication and / or saline through a tubing coupled to a syringe port 229 of the syringe 230. As shown, the syringe 230 can receive, store and / or dispense medication and / or saline in a chamber defined therein.

[0039] As shown, the proximal syringe portion 231 of the syringe 230 can store medical fluids, such as medication and saline, in the syringe cavity 236. In the illustrated embodiment, the medication plunger 240 can move within the syringe cavity 236 to define a medication chamber 242 within the proximal syringe portion 231. Optionally, the volume of the medication chamber 242 is defined by the position of the medication plunger 240 relative to the proximal end 232 of the syringe 230. In the depicted example, the medication chamber 242 can store medication.

[0040] In some embodiments, the medication chamber 242 is in fluid communication with the syringe port 229 of the syringe 230. Optionally, the medication plunger 240 may include one or more seals 244 to seal against the walls of the syringe cavity 236 to prevent accidental fluid transfer or mixing.

[0041] In addition, the drug plunger 240 can be moved by the drug plunger shaft 246. In some embodiments, the drug plunger 240 can be pulled distally to expand the drug chamber 242 and draw more drug or medical fluid through the syringe port 229. In some embodiments, the drug plunger 240 can be pushed proximally to collapse the drug chamber 242 and expel the drug or medical fluid from the drug chamber 242 through the syringe port 229.

[0042] In the illustrated embodiment, the saline plunger 250 is movable within the syringe cavity 236 to define a saline chamber 252 within the proximal syringe portion 231. In some embodiments, the saline plunger 250 and the drug plunger 240 cooperate to define the saline chamber 252 within the syringe cavity 236. Optionally, the volume of the saline chamber 252 is defined by the positions of the drug plunger 240 and the saline plunger 250. In the depicted example, the saline chamber 252 can store saline or other medical fluids.

[0043] Optionally, the saline plunger 250 may include one or more seals 254 to seal against the walls of the syringe cavity 236 to prevent accidental fluid transfer or mixing.

[0044] In addition, the saline plunger 250 can be moved by the saline plunger shaft 256. In some embodiments, the saline plunger 250 can be pulled distally to expand the saline chamber 252 and draw in more saline or medical fluid. In some embodiments, the saline plunger 250 can be pushed proximally to collapse the saline chamber 252 and expel saline or medical fluid from the saline chamber 252.

[0045] As previously described, during administration of medication to a patient (eg, a fluid restricted patient), medication may be dispensed from medication chamber 242 and then saline may be dispensed from saline chamber 252 to advance medication remaining in the tubing.

[0046] In the depicted example, medication may be dispensed from syringe 230 by advancing medication plunger 240 within syringe cavity 236. As a result, medication may be delivered from syringe 230 through syringe port 229.

[0047] In some embodiments, syringe 230 may include a priming mechanism or actuation mechanism 270 to automate, control, or otherwise simplify the advancement of medication plunger 240 to facilitate priming of the medication into the IV tubing. Optionally, actuation mechanism 270 may be configured to introduce a sufficient volume of medication from medication chamber 242 into the IV tubing to completely fill or prime the IV line prior to administering the medication to a patient.

[0048] In the illustrated embodiment, the actuation mechanism 270 may utilize a biasing member, such as a tension spring 274 , to advance the medicament plunger 240 within the syringe cavity 236 .

[0049] Optionally, the extension spring 274 can be coupled to the proximal syringe portion 231 at a proximal end 276 of the extension spring 274 and coupled to the actuation mechanism 270 at a distal end 275 of the extension spring 274. In some embodiments, the actuation mechanism 270 extends from, or is generally coupled to, the drug plunger shaft 246. In addition, the extension spring 274 can be disposed around the drug plunger shaft 246.

[0050] As shown, the extension spring 274 can be preloaded or biased to facilitate advancing the drug plunger 240 when the extension spring 274 is released or activated. In the depicted example, the extension spring 274 can be extended or biased from a static length to an extended stretched length. In some embodiments, the biasing member can be compressed from a static length to a shortened compressed length.

[0051] As shown, the tension spring 274 can be preloaded or elongated by retracting the actuation mechanism 270, which causes the tension spring 274 to extend. In some embodiments, the actuation mechanism 270 can be locked or held in place, thereby preventing the drug plunger 240 from being advanced by the retention mechanism prior to priming. In the illustrated embodiment, the retention mechanism includes a priming trigger 280 with a shaft 282 that extends through the distal syringe portion 233 and through the through hole 272 of the actuation mechanism 270, releasably coupling the actuation mechanism 270 to the distal syringe portion 233. The priming trigger 280 can extend through a slot 284 of the distal syringe portion 233.

[0052] Optionally, the tension applied to the extension spring 274 may be adjusted by changing the position of the actuation mechanism 270 relative to the distal syringe portion 233 and inserting the priming trigger 280 through the slot 284 (aligned with the through hole 272 of the actuation mechanism 270).

[0053] Figure 6 According to various aspects of the present disclosure Figure 5 A front view of a syringe 230 in which the syringe body is hidden and the priming trigger 280 is removed. As shown, the priming mechanism of the syringe 230 can be activated by removing the priming trigger 280 from the syringe 230.

[0054] By removing the priming trigger 280, the extension spring 274 is allowed to contract to advance the medication plunger shaft 246, thereby advancing the medication plunger 240. By advancing the medication plunger 240, the medication within the medication chamber 242 can be advanced through the IV tubing and prime the IV tubing. As described herein, during the priming process, the medication plunger 240 can be advanced a desired or predetermined amount corresponding to the volume of the IV tubing.

[0055] Figure 7 According to various aspects of the present disclosure Figure 5 230, wherein the syringe body is hidden and the priming mechanism is actuated. In the illustrated embodiment, the drug plunger 240 can be further actuated to administer any residual drug in the drug chamber 242 into the IV tubing and to the patient. In some embodiments, the drug plunger shaft 246 can be actuated to advance the drug plunger 240. For example, the distal end 234 of the distal syringe portion 233 can be advanced toward the proximal end 232 to advance the drug plunger 240. In some embodiments, the extension 238 of the proximal syringe portion 231 can allow a clinician or a syringe pump to advance the distal syringe portion 233 relative to the proximal syringe portion 231.

[0056] Figure 8 According to various aspects of the present disclosure Figure 5 230, wherein the syringe body is hidden and the syringe is actuated. In the illustrated embodiment, the saline plunger 250 can be actuated to administer saline from the saline chamber 252 into the IV tubing, thereby "pushing" or delivering any residual medication in the IV tubing to the patient. In some embodiments, the saline plunger shaft 256 can be actuated to advance the saline plunger 250. In some embodiments, the same actuation method used for the medication plunger 240 can be used to actuate the saline plunger 250.

[0057] For example, the distal end 234 of the distal syringe portion 233 can be advanced toward the proximal end 232 to advance the saline plunger 250. In some embodiments, the extension 238 of the proximal syringe portion 231 can allow a clinician or a syringe pump to advance the distal syringe portion 233 relative to the proximal syringe portion 231.

[0058] In some embodiments, saline from saline chamber 252 may be pushed through or around drug chamber 242 to exit syringe 230 via syringe port 229 .

[0059] The present disclosure is provided to enable any person skilled in the art to practice the various aspects described herein. The present disclosure provides various examples of the subject technology, and the subject technology is not limited to these examples. Various modifications to these aspects will be apparent to those skilled in the art, and the general principles defined herein may be applied to other aspects.

[0060] Unless otherwise specified, references to elements in the singular are not intended to mean "one and only one," but rather "one or more." Unless otherwise specified, the term "some" refers to one or more. Masculine pronouns (e.g., his) include the feminine and neuter genders (e.g., her and its) and vice versa. Headings and subheadings, if any, are used for convenience only and do not limit the invention.

[0061] The word "exemplary" is used herein to mean "serving as an example or illustration." Any aspect or design described herein as "exemplary" is not necessarily to be construed as preferred or advantageous over other aspects or designs. In one aspect, the various alternative configurations and operations described herein may be considered to be at least equivalent.

[0062] Phrases such as "aspects" do not mean that such aspects are essential to the subject technology or that such aspects apply to all configurations of the subject technology. Disclosures related to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples. Phrases such as "aspects" may refer to one or more aspects, and vice versa. Phrases such as "embodiments" do not mean that such embodiments are essential to the subject technology or that such embodiments apply to all configurations of the subject technology. Disclosures related to an embodiment may apply to all embodiments, or one or more embodiments. An embodiment may provide one or more examples. Phrases such as "embodiments" may refer to one or more embodiments, and vice versa. Phrases such as "configurations" do not mean that such configurations are essential to the subject technology or that such configurations should apply to all configurations of the subject technology. Disclosures related to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples. Phrases such as "configurations" may refer to one or more configurations, and vice versa.

[0063] In one aspect, unless otherwise indicated, all measurements, values, ratings, positions, sizes, dimensions, and other specifications set forth in this specification (including in the appended claims) are approximate and not exact. In one aspect, they are intended to have a reasonable range consistent with the functions to which they are related and with the customary practices in the art to which they belong.

[0064] In one aspect, the term "coupled" or the like may refer to a direct coupling. In another aspect, the term "coupled" or the like may refer to an indirect coupling.

[0065] Terms such as "top", "bottom", "front", "rear", etc., if used in this disclosure, should be understood to refer to an arbitrary reference frame, not a general gravitational reference frame. Thus, the top surface, bottom surface, front surface, and rear surface may extend upward, downward, diagonally, or horizontally in a gravitational reference frame.

[0066] Various objects may be arranged differently (e.g., arranged in a different order, or divided in a different manner), all without departing from the scope of the subject technology. All structural and functional equivalents of the elements throughout the various aspects described in this disclosure that are known or will be known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be covered by the claims. In addition, nothing disclosed herein is intended to be contributed to the public, regardless of whether such disclosure is explicitly stated in the claims. No claim element shall be interpreted according to the provisions of the sixth paragraph of 35 U.S.C. § 112, unless the element is explicitly stated using the phrase "means for...", or in the case of a method claim, the element is stated using the phrase "step for...". In addition, to the extent that the terms "including", "having", etc. are used, such terms are intended to be included in a manner similar to the term "including", as explained when "including" is used as a transitional word in the claims.

[0067] The title, background technology, content of the invention, description of the drawings and abstract of the specification of the present disclosure are incorporated into the present disclosure and are provided as illustrative examples of the present disclosure, rather than as restrictive descriptions. The present invention is submitted in the following understanding manner, that is, they will not be used to limit the scope or meaning of the claims. In addition, in the specific implementation, it can be seen that the description provides illustrative examples, and for the purpose of simplifying the present disclosure, various features are combined together in various embodiments. This disclosure method should not be interpreted as reflecting the intention that the subject matter claimed for protection requires more features than the features explicitly stated in each claim. On the contrary, as reflected in the attached claims, the subject matter of the invention lies in less than all the features of a single disclosed construction or operation. The attached claims are incorporated into the specific implementation at this time, and each claim exists independently as a subject matter claimed for protection.

[0068] The claims are not intended to be limited to the aspects described herein, but are to be accorded the full scope consistent with the language of the claims and including all legal equivalents. Nevertheless, no claim is intended to encompass subject matter that fails to satisfy the requirements of 35 U.S.C. §101, 102, or 103, nor should they be interpreted in such a manner.

Claims

1. An independent valve for medical fluids, comprising: a valve body defining a drug flow path, a return flow path, and a catheter flow path configured to be in fluid communication with the catheter; as well as an actuatable valve element disposed within the valve body, wherein in a priming position the valve element is configured to allow fluid communication between the drug flow path and the return flow path, and in a dispensing position the valve element is configured to be actuated to allow fluid communication between the drug flow path and the catheter flow path, The independent valve is configured to be connected to a first end of a flexible tube, and the syringe is connected to a second end of the flexible tube.

2. The independent valve according to claim 1, wherein: The valve element is configured to be actuated to a dispensing position by pressurizing the drug flow path and the return flow path to a cracking pressure.

3. The independent valve according to claim 1, wherein: The valve element is configured to be actuated to a dispensing position by actuating the valve body.

4. A drug delivery system comprising: Flexible pipe fittings; A syringe coupled to the first end of the flexible tubing, the syringe comprising: a syringe body defining a syringe cavity; a first plunger disposed within the syringe cavity and defining a first chamber within the syringe cavity; and a second plunger disposed within the syringe cavity, the second plunger defining a second chamber within the syringe cavity; and a valve coupled to the second end of the flexible tubing, the valve comprising: a valve body defining a medication valve flow path in fluid communication with the first chamber, a return valve flow path in fluid communication with the second chamber, and a catheter flow path in fluid communication with a catheter; and A valve element is disposed within the valve body, wherein in a priming position, the valve element is configured to allow fluid communication between the first chamber and the second chamber, and in a dispensing position, the valve element is configured to allow fluid communication between the first chamber and the catheter flow path.

5. The drug delivery system according to claim 4, wherein: The flexible tubing is a dual-lumen tubing defining a medication tubing flow path and a return tubing flow path, wherein the medication tubing flow path is configured to allow fluid communication between the first chamber and the medication valve flow path, and the return tubing flow path is configured to allow fluid communication between the second chamber and the return valve flow path.

6. The drug delivery system according to claim 5, wherein: The flexible tube is longer than the conduit.

7. The drug delivery system according to claim 4, wherein: The valve element is configured to be actuated to a dispensing position by pressurizing the first chamber and the second chamber to a cracking pressure.

8. The drug delivery system according to claim 4, wherein: The valve element is configured to be actuated to a dispensing position by actuating the valve body.